Metabolomics study of COVID-19 patients in four different clinical stages
Abstract SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) is the coronavirus strain causing the respiratory pandemic COVID-19 (coronavirus disease 2019). To understand the pathobiology of SARS-CoV-2 in humans it is necessary to unravel the metabolic changes that are produced in the indiv...
Main Authors: | Alberto Valdés, Lorena Ortega Moreno, Silvia Rojo Rello, Antonio Orduña, David Bernardo, Alejandro Cifuentes |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2022-01-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-022-05667-0 |
Similar Items
-
In vivo neuroprotective capacity of a Dunaliella salina extract - comprehensive transcriptomics and metabolomics study
by: Alberto Valdés, et al.
Published: (2024-01-01) -
Altered Surface Expression of Insulin-Degrading Enzyme on Monocytes and Lymphocytes from COVID-19 Patients Both at Diagnosis and after Hospital Discharge
by: Carlos M. González-Casimiro, et al.
Published: (2022-09-01) -
The Complex Metabolomics Crosstalk Triggered by Four Molecular Elicitors in Tomato
by: Giusy Iula, et al.
Published: (2022-03-01) -
Metabolomic Analysis of Germinated Brown Rice at Different Germination Stages
by: Hoon Kim, et al.
Published: (2020-08-01) -
Blood Plasma Metabolome Profiling at Different Stages of Renal Cell Carcinoma
by: Dmitry L. Maslov, et al.
Published: (2022-12-01)